Skip to main content
NCBI home page
Environmental Health Perspectives logoLink to Environmental Health Perspectives
. 1996 Dec;104(Suppl 6):1251–1256. doi: 10.1289/ehp.961041251

p-Benzoquinone, a reactive metabolite of benzene, prevents the processing of pre-interleukins-1 alpha and -1 beta to active cytokines by inhibition of the processing enzymes, calpain, and interleukin-1 beta converting enzyme.

G F Kalf 1, J F Renz 1, R Niculescu 1
PMCID: PMC1469767  PMID: 9118901

Abstract

Chronic exposure of humans of benzene affects hematopoietic stem and progenitor cells and leads to aplastic anemia. The stromal macrophage, a target of benzene toxicity, secretes interleukin-1 (IL-1), which induces the stromal fibroblast to synthesize hematopoietic colony-stimulating factors. In a mouse model, benzene causes an acute marrow hypocellularity that can be prevented by the concomitant administration of IL-1 alpha. The ability of benzene to interfere with the production and secretion of IL-1 alpha was tested. Stromal macrophages from benzene-treated mice were capable of the transcription to the IL-1 alpha gene and the translation of the message but showed an inability to process the 34-kDa pre-IL-1 alpha precursor to the 17-kDa biologically active cytokine. Treatment of normal murine stromal macrophages in culture with hydroquinone (HQ) also showed an inhibition in processing of pre-IL-1 alpha. Hydroquinone is oxidized by a peroxidase-mediated reaction in the stromal macrophage to p-benzoquinone, which interacts with the sulfhydryl (SH) groups of proteins and was shown to completely inhibit the activity of calpain, the SH-dependent protease that cleaves pre-IL-1 alpha. In a similar manner, HQ, via peroxidase oxidation to p-benzoquinone, was capable of preventing the IL-1 beta autocrine stimulation of growth of human B1 myeloid tumor cells by preventing the processing of pre-IL-1 beta to mature cytokine. Benzoquinone was also shown to completely inhibit the ability of the SH-dependent IL-1 beta converting enzyme. Thus benzene-induced bone marrow hypocellularity may result from apoptosis of hematopoietic progenitor cells brought about by lack of essential cytokines and deficient IL-1 alpha production subsequent to the inhibition of calpain by p-benzoquinone and the prevention of pre-IL-1 processing.

Full text

PDF
1251

Images in this article

1253Figure 2.
on p.1253
1253Figure 3.
on p.1253
1254Figure 6.
on p.1254
1255Figure 7.
on p.1255
1255Figure 8.
on p.1255

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aksoy M. Malignancies due to occupational exposure to benzene. Am J Ind Med. 1985;7(5-6):395–402. doi: 10.1002/ajim.4700070506. [DOI] [PubMed] [Google Scholar]
  2. Black R. A., Kronheim S. R., Sleath P. R. Activation of interleukin-1 beta by a co-induced protease. FEBS Lett. 1989 Apr 24;247(2):386–390. doi: 10.1016/0014-5793(89)81376-6. [DOI] [PubMed] [Google Scholar]
  3. Bradford H. N., Schmaier A. H., Colman R. W. Kinetics of inhibition of platelet calpain II by human kininogens. Biochem J. 1990 Aug 15;270(1):83–90. doi: 10.1042/bj2700083. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Brandwein S. R. Regulation of interleukin 1 production by mouse peritoneal macrophages. Effects of arachidonic acid metabolites, cyclic nucleotides, and interferons. J Biol Chem. 1986 Jul 5;261(19):8624–8632. [PubMed] [Google Scholar]
  5. Carruth L. M., Demczuk S., Mizel S. B. Involvement of a calpain-like protease in the processing of the murine interleukin 1 alpha precursor. J Biol Chem. 1991 Jul 5;266(19):12162–12167. [PubMed] [Google Scholar]
  6. Cerretti D. P., Kozlosky C. J., Mosley B., Nelson N., Van Ness K., Greenstreet T. A., March C. J., Kronheim S. R., Druck T., Cannizzaro L. A. Molecular cloning of the interleukin-1 beta converting enzyme. Science. 1992 Apr 3;256(5053):97–100. doi: 10.1126/science.1373520. [DOI] [PubMed] [Google Scholar]
  7. Cohen A., Petsche D., Grunberger T., Freedman M. H. Interleukin 6 induces myeloid differentiation of a human biphenotypic leukemic cell line. Leuk Res. 1992 Aug;16(8):751–760. doi: 10.1016/0145-2126(92)90153-x. [DOI] [PubMed] [Google Scholar]
  8. Dinarello C. A. Interleukin-1. Ann N Y Acad Sci. 1988;546:122–132. doi: 10.1111/j.1749-6632.1988.tb21627.x. [DOI] [PubMed] [Google Scholar]
  9. Gascon P., Scala G. Decreased interleukin-1 production in aplastic anemia. Am J Med. 1988 Nov;85(5):668–674. doi: 10.1016/s0002-9343(88)80240-7. [DOI] [PubMed] [Google Scholar]
  10. Goldstein B. D. Benzene toxicity. Occup Med. 1988 Jul-Sep;3(3):541–554. [PubMed] [Google Scholar]
  11. Kalf G. F. Recent advances in the metabolism and toxicity of benzene. Crit Rev Toxicol. 1987;18(2):141–159. doi: 10.3109/10408448709089859. [DOI] [PubMed] [Google Scholar]
  12. Kobayashi Y., Yamamoto K., Saido T., Kawasaki H., Oppenheim J. J., Matsushima K. Identification of calcium-activated neutral protease as a processing enzyme of human interleukin 1 alpha. Proc Natl Acad Sci U S A. 1990 Jul;87(14):5548–5552. doi: 10.1073/pnas.87.14.5548. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Laskin D. L., MacEachern L., Snyder R. Activation of bone marrow phagocytes following benzene treatment of mice. Environ Health Perspect. 1989 Jul;82:75–79. doi: 10.1289/ehp.898275. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Lewis J. G., Odom B., Adams D. O. Toxic effects of benzene and benzene metabolites on mononuclear phagocytes. Toxicol Appl Pharmacol. 1988 Feb;92(2):246–254. doi: 10.1016/0041-008x(88)90384-5. [DOI] [PubMed] [Google Scholar]
  15. Miller A. C., Schattenberg D. G., Malkinson A. M., Ross D. Decreased content of the IL1 alpha processing enzyme calpain in murine bone marrow-derived macrophages after treatment with the benzene metabolite hydroquinone. Toxicol Lett. 1994 Nov;74(2):177–184. doi: 10.1016/0378-4274(94)90096-5. [DOI] [PubMed] [Google Scholar]
  16. Nakao S., Matsushima K., Young N. Decreased interleukin 1 production in aplastic anaemia. Br J Haematol. 1989 Mar;71(3):431–436. doi: 10.1111/j.1365-2141.1989.tb04302.x. [DOI] [PubMed] [Google Scholar]
  17. Niculescu R., Kalf G. F. A morphological analysis of the short-term effects of benzene on the development of the hematological cells in the bone marrow of mice and the effects of interleukin-1 alpha on the process. Arch Toxicol. 1995;69(3):141–148. doi: 10.1007/s002040050150. [DOI] [PubMed] [Google Scholar]
  18. Pirozzi S. J., Renz J. F., Kalf G. F. The prevention of benzene-induced genotoxicity in mice by indomethacin. Mutat Res. 1989 Mar;222(3):291–298. doi: 10.1016/0165-1218(89)90146-8. [DOI] [PubMed] [Google Scholar]
  19. Renz J. F., Kalf G. F. Role for interleukin-1 (IL-1) in benzene-induced hematotoxicity: inhibition of conversion of pre-IL-1 alpha to mature cytokine in murine macrophages by hydroquinone and prevention of benzene-induced hematotoxicity in mice by IL-1 alpha. Blood. 1991 Aug 15;78(4):938–944. [PubMed] [Google Scholar]
  20. Rickert D. E., Baker T. S., Bus J. S., Barrow C. S., Irons R. D. Benzene disposition in the rat after exposure by inhalation. Toxicol Appl Pharmacol. 1979 Jul;49(3):417–423. doi: 10.1016/0041-008x(79)90441-1. [DOI] [PubMed] [Google Scholar]
  21. Schlosser M. J., Kalf G. F. Metabolic activation of hydroquinone by macrophage peroxidase. Chem Biol Interact. 1989;72(1-2):191–207. doi: 10.1016/0009-2797(89)90027-6. [DOI] [PubMed] [Google Scholar]
  22. Schmaier A. H., Bradford H., Silver L. D., Farber A., Scott C. F., Schutsky D., Colman R. W. High molecular weight kininogen is an inhibitor of platelet calpain. J Clin Invest. 1986 May;77(5):1565–1573. doi: 10.1172/JCI112472. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Stanley E. R., Bartocci A., Patinkin D., Rosendaal M., Bradley T. R. Regulation of very primitive, multipotent, hemopoietic cells by hemopoietin-1. Cell. 1986 Jun 6;45(5):667–674. doi: 10.1016/0092-8674(86)90781-6. [DOI] [PubMed] [Google Scholar]
  24. Suzuki K., Hayashi H., Hayashi T., Iwai K. Amino acid sequence around the active site cysteine residue of calcium-activated neutral protease (CANP). FEBS Lett. 1983 Feb 7;152(1):67–70. doi: 10.1016/0014-5793(83)80483-9. [DOI] [PubMed] [Google Scholar]
  25. Thomas D. J., Reasor M. J., Wierda D. Macrophage regulation of myelopoiesis is altered by exposure to the benzene metabolite hydroquinone. Toxicol Appl Pharmacol. 1989 Mar 1;97(3):440–453. doi: 10.1016/0041-008x(89)90249-4. [DOI] [PubMed] [Google Scholar]
  26. Thornberry N. A., Bull H. G., Calaycay J. R., Chapman K. T., Howard A. D., Kostura M. J., Miller D. K., Molineaux S. M., Weidner J. R., Aunins J. A novel heterodimeric cysteine protease is required for interleukin-1 beta processing in monocytes. Nature. 1992 Apr 30;356(6372):768–774. doi: 10.1038/356768a0. [DOI] [PubMed] [Google Scholar]
  27. Yang Y. C., Tsai S., Wong G. G., Clark S. C. Interleukin-1 regulation of hematopoietic growth factor production by human stromal fibroblasts. J Cell Physiol. 1988 Feb;134(2):292–296. doi: 10.1002/jcp.1041340217. [DOI] [PubMed] [Google Scholar]
  28. Zucali J. R., Dinarello C. A., Oblon D. J., Gross M. A., Anderson L., Weiner R. S. Interleukin 1 stimulates fibroblasts to produce granulocyte-macrophage colony-stimulating activity and prostaglandin E2. J Clin Invest. 1986 Jun;77(6):1857–1863. doi: 10.1172/JCI112512. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Environmental Health Perspectives are provided here courtesy of National Institute of Environmental Health Sciences

RESOURCES